blinded randomized placebo controlled

Related by string. * blinder . Blinded . Blinds : Venetian blinds dangled . blinding snowstorm blew . vertical blinds / randomizing . randomizer . Randomized : randomized controlled trial . randomized controlled trials / placebos . Placebos : placebo controlled clinical trials . blind placebo controlled / controlling . controller : obtaining controlled substance . Controller * *

Related by context. Frequent words. (Click for all words.) 72 blinded placebo controlled 72 double blinded placebo 71 placebo controlled clinical 71 Phase 1b trial 70 phase IIa 70 phase IIb 69 Phase 2a trial 68 Phase 1b clinical 68 Phase Ib 68 SCH # 68 Pivotal Phase III 68 Phase 1b 68 safety tolerability pharmacokinetics 67 BMS # 67 nab paclitaxel 67 relapsed refractory multiple myeloma 67 Pivotal Phase 67 active comparator 66 dose escalation trial 66 TYKERB 66 PRECiSE 66 dose cohorts 66 blind randomized placebo 66 MIRCERA 65 peginterferon alfa 2b 65 randomized Phase III 65 glatiramer acetate 65 prospective randomized controlled 65 RRMS patients 65 Phase 2a 65 metastatic hormone refractory 65 phase 2a 65 Phase 2a clinical 65 administered subcutaneously 65 pertuzumab 65 dose regimens 65 Phase 2b clinical 65 romidepsin 65 tolerated dose MTD 65 Phase IIa trial 64 label dose escalation 64 lacosamide 64 investigational oral 64 Phase 2b study 64 Phase 1a 64 blind placebo controlled 64 mg kg dose 64 ZD# [001] 64 dose escalation study 64 Carfilzomib 64 nitazoxanide 64 prospective observational 64 placebo controlled 64 plus dexamethasone 64 Vilazodone 64 confirmatory Phase III 64 mg BID 64 Pivotal Trial 64 Phase IIa clinical 64 tanespimycin 64 Phase IIa 64 JANUVIA 64 diabetic neuropathic pain 64 placebo controlled randomized 64 multicenter randomized 64 vicriviroc 64 Phase Ia 64 Phase 2b 64 double blind placebo 64 mycophenolate mofetil 64 single ascending dose 64 BAY #-# 63 randomized placebo controlled 63 tocilizumab 63 blind randomized 63 Phase 2b trial 63 multicentre 63 registrational 63 abiraterone acetate 63 axitinib 63 Phase III Clinical Trial 63 pharmacodynamic effects 63 irbesartan 63 celgosivir 63 Phase IIb 63 STELARA 63 Amrubicin 63 mg QD 63 transcriptase inhibitor NNRTI 63 thymalfasin 63 label multicenter 63 multicenter randomized double 63 LIALDA 63 HER2 positive metastatic breast 62 Pharmacokinetic 62 blind randomized controlled 62 ISENTRESS 62 IMC A# 62 tezampanel 62 HGS ETR1 62 muraglitazar

Back to home page